Steve Pakola
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steve Pakola
The proxy statement of REGENXBIO Inc. reports total compensation of $3,908,793 for Steve Pakola in fiscal 2019, including a base salary of $305,301. Steve Pakola has spoken on 2 earnings calls across 1 company, most recently for REGENXBIO Inc. on August 6, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
REGENXBIO Inc. (RGNX)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- Kenneth T. Mills Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | REGENXBIO Inc. (RGNX) | Senior Vice President, Chief Medical Officer | $305,301 | $3,908,793 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.